United States Pharmaceutical Contrast Testing Laboratories Market Size By Type (Cell And Gene Therapy, In-Process And Product Release Testing), By Application (Analytical Testing, Method Development), By Geographic Scope And Forecast

United States Pharmaceutical Contrast Testing Laboratories Market Size And Forecast

United States Pharmaceutical Contrast Testing Laboratories Market size was valued at USD 789.37 Million in 2023 and is projected to reach USD 1,499.11 Million by 2030, growing at a CAGR of 8.67% from 2024 to 2030.

Surge in the market demand for biosimilars and biopharmaceutical products and pricing benefits associated with outsourcing services are the factors driving market growth. The United States Pharmaceutical Contrast Testing Laboratories Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

United States Pharmaceutical Contrast Testing Laboratories Market Definition

Pharmaceutical Contract Testing Laboratories are specializing organizations that offer analytical and testing services to biotechnology and pharmaceutical firms. These labs provide various services throughout their research and development to ensure pharmaceutical products’ effectiveness, safety, and quality. Contract testing labs aim to help pharmaceutical companies comply with industry standards and legal obligations. A contract testing laboratory is an independent company that conducts testing or scientific research for outside clients. These outside laboratories finish tasks that their clients cannot perform on themselves. These labs perform analytical tests to evaluate the quality, purity, and chemical makeup of pharmaceutical items. This involves conducting tests for chemicals, impurities, and active substances.

The production of reliable information depends critically on quality and safety testing. There are several advantages to using contract testing laboratories for smaller or startup businesses and more extensive enterprise operations that might lack the core capability to carry out specific tests. Contract testing laboratories play a crucial role in supporting clinical trials by carrying out the many tests necessary for investigational pharmaceuticals and ensuring they meet safety and efficacy criteria. Whether for product development, manufacturing, or quality control, contract testing laboratories are flexible in offering tailored testing solutions depending on the unique demands of pharmaceutical companies.

United States Pharmaceutical Contrast Testing Laboratories Market Overview

The United States Pharmaceutical Contrast Testing Laboratories Market is witnessing significant growth owing to various driving factors such as Pricing Benefits associated with outsourcing services, surge in the market demand for biosimilar and biopharmaceutical products, and others. The surge in market demand for biosimilar and biopharmaceutical products has contributed significantly to the growth of the U.S. Pharmaceutical Contract Testing Laboratories Market. Biological products constitute a varied category of substances, typically comprising large and intricate molecules. These products are commonly generated using biotechnology within a living system, such as a microorganism, plant cell, or animal cell. They often present challenges in characterization compared to small molecule drugs.

However, the increase in research and development (R&D) expenditures presents a significant opportunity for the U.S. Pharmaceutical Contract Testing Laboratories Market. Government funding often leads to an uptick in R&D initiatives within the pharmaceutical sector. As research activities expand, the demand for specialized testing services provided by contract laboratories grows, creating a favorable market opportunity.

The advantageous pricing benefits of outsourcing services propel the U.S. Pharmaceutical Contract Testing Laboratories market’s growth. As pharmaceutical companies seek cost-effective solutions, the economic advantages of outsourcing testing services contribute significantly to expanding the contract testing laboratories sector. This trend enables companies to optimize their expenditures while accessing specialized testing expertise, fostering the overall growth and competitiveness of the market. Contract testing laboratories often operate on a larger scale, allowing them to spread their fixed costs over a higher volume of testing services. This results in cost savings, which can be passed on to pharmaceutical companies through competitive pricing.

United States Pharmaceutical Contrast Testing Laboratories Market Segmentation Analysis

The United States Pharmaceutical Contrast Testing Laboratories Market is segmented on the basis of Type, Application, and Geography.

United States Pharmaceutical Contrast Testing Laboratories Market, By Type

• Cell and Gene Therapy
• In-Process and Product Release Testing
• Finished Pharmaceutical Products Testing
• Environmental Samples
• Others

To Get a Summarized Market Report By Type-

Based on Type, The market is segmented into Cell and Gene Therapy, In-Process and Product Release Testing, Finished Pharmaceutical Products Testing, Environmental Samples, and Others. The United States Pharmaceutical Contrast Testing Laboratories Market is experiencing a scaled level of attractiveness in the “Type” segment. Cell and Gene Therapy accounted for the largest market share of 27.7% in 2022, with a market value of USD 218.28 Million and is projected to grow at a CAGR of 9.27% during the forecast period. In-Process and Product Release Testing was the second-largest market in 2022, valued at USD 181.55 Million in 2022; it is projected to grow at a CAGR of 8.80%.

Gene therapy is a medical strategy that fixes the underlying genetic issue to treat or prevent disease. Instead of utilizing medications or surgery to treat an illness, doctors can use gene therapy procedures to change a person’s genetic composition. Cell and gene therapy are innovative approaches in the field of medicine that involve the manipulation of cells or genes to treat diseases. Pharmaceutical contract testing laboratories in the United States support the development, testing, and commercialization of these advanced therapies.

United States Pharmaceutical Contrast Testing Laboratories Market, By Application

• Analytical Testing
• Method Development
• Stability Testing
• Other Testing

To Get a Summarized Market Report By Application-

Based on Application, The market is segmented into Analytical Testing, Method Development, Stability Testing, and Other Testing. The United States Pharmaceutical Contrast Testing Laboratories Market is experiencing a scaled level of attractiveness in the Application segment. The Analytical Testing segment has a prominent presence and holds the major share of the U.S. market. Analytical Testing segment is anticipated to account for the significant market share of 26.6% in 2022. The segment is projected to gain incremental market value of USD 209.74 Million and is projected to grow at a CAGR of 9.16% between 2023 and 2030.

Analytical Contract Research Organizations, Analytical Scientific Research Facilities, and U.S. Analytical Contract Laboratories are all partners of Contract Laboratories. High-quality analytical testing services for the CMC (Chemistry, Manufacturing, and Controls) parameters necessary for drug development and release testing are the area of expertise for Analytical. The analytical testing laboratory, which is FDA-registered and follows cGMP guidelines, is fully prepared to do all necessary tests and related services, such as microbiology, analytical development, and storage and stability testing.

United States Pharmaceutical Contrast Testing Laboratories Market, By Geography

• West
• Northeast
• Southeast
• Midwest
• Southwest

Based on Geography, The United States Pharmaceutical Contrast Testing Laboratories Market is segmented into West, Northeast, Southeast, Midwest, and Southwest. The United States Pharmaceutical Contrast Testing Laboratories Market is experiencing a scaled level of attractiveness in the West region. The West region has a prominent presence and holds the major share of the U.S. market. West is anticipated to account for the significant market share of 25.3% by 2030. The region is projected to gain incremental market value of USD 193.02 Million and is projected to grow at a CAGR of 9.12% between 2023 and 2030.

West is the most significant region driving the growth of the region’s pharmaceutical contrast testing laboratories market. The pharmaceutical industry is subject to strict regulatory standards. Contract testing laboratories play a crucial role in helping companies comply with these regulations, ensuring the quality and safety of pharmaceutical products. In regions with an intense concentration of pharmaceutical companies, such as the U.S., contract testing laboratories are especially vital in helping businesses comply with regulatory requirements. WHO has developed international regulatory standards covering stability, packaging, storage, and bioequivalence. It is essential to ensure that active medicinal ingredients are stable and unaffected by storage or packaging materials.

Key Players

The “United States Pharmaceutical Contrast Testing Laboratories Market” study report will provide a valuable insight with an emphasis on the market. The major players in the market are Eurofins Scientific, WuXi AppTec, Millipore Sigma (Merck), Pace Analytical Services, LLC, Catalent, Inc., Laboratory Corporation of America Holdings (LabCorp), PPD, Inc. (Thermo Fisher Scientific), Element Materials Technology, ALS Ltd., Intertek, SGS S.A., and Charles River Laboratories International Inc. This section provides a company overview, ranking analysis, company regional and industry footprint, and ACE Matrix.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with Coating Type benchmarking and SWOT analysis.

Key Developments

• In July 2023, MilliporeSigma added 98,000 square feet of lab space to its Lenexa, Kansas, facility to enhance its ability to make cell culture media. With this advancement, Lenexa becomes North America’s largest Center of Excellence and dry powder cell culture media facility.
• In February 2023, Eurofins launched a novel test designed to evaluate the growth and durability of Chimeric Antigen Receptor TCell (CAR-T) therapy in individuals suffering from B cell lymphomas and pre-B cell acute lymphoblastic leukemia.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.